Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Growth Hormone Treatment of Children After Intrauterine Growth Retardation

This trial is conducted in Europe. The aim of this trial is to assess and compare the efficacy and safety of two dose levels of somatropin over a long period (till final height is reached). This trial is an extension to trials GHRETARD/BDP/14/NL (a 2-year initial trial) and GHRETARD/BPD/20/NL (a 2-year extension trial).

Inclusion Criteria:

• Completion of the GHRETARD/BPD/20/NL trial
• Written informed consent from child and/or parents/guardians before continuation in the extension trial